Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio
Published: 11 November 2021
-
Views:
5762 -
Likes:
7
-
Views:
5762 -
Likes:
7
-
12m 42sPart 1 Introduction and The Pascal Platform for MR Treatment Didier Tchétché, Sam Dawkins, Philipp Lurz, Peter Lüdike, Sam Dawkins, Nicole Karam, Andreas Rück, Jorg Hausleiter, Michael Böhm
-
12m 18sPart 2 PASCAL MR Live Case – Patient Presentation and Strategy Didier Tchétché, Philipp Lurz, Peter Lüdike
-
9m 39sPart 3 PASCAL Platform – Successful and Durable Treatment of MR Sam Dawkins, Didier Tchétché
Overview
This on-demand version of the broadcast "Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio" sees event Chair Didier Tchétché (Clinic Pasteur, Toulouse, FR) joined by an internationally-respected panel, as they explore key elements of the PASCAL platform. Dr Sam Dawkins (John Radcliffe Hospital, UK) explores its practical application for MR, Dr Nicole Karam (European Hospital Georges Pompidou, FR) for TR; whilst Dr Andreas Ruck (Karolinska University Hospital, SE) provides additional insight with a case-based review of its successful, safe application for Tricuspid Valve repair. Prof Jörg Hausleiter (Ludwig-Maximilians Universitat, Munich, DE) looks to the future of TR treatment, with a review of the EVOQUE replacement system. Prof Michael Böhm provides insight from a heart failure perspective throughout the discussions.
The presentations and discussions are set against the back-drop of a live case from the Heart Center Leipzig, under the guidance with Prof Philipp Lurz with Prof Peter Ludike.
Learning objectives
- To discuss the clinical evidence of PASCAL repair system in the treatment of MR and TR
- To learn from case examples how the PASCAL repair system improves outcomes of patients with MR and TR
- To participate in a step-by-step LIVE demonstration of percutaneous mitral leaflet repair with the PASCAL repair system
Audience
- Interventional Cardiologists
- Cardiologists
More from this programme
Part 1
Event Introduction and the PASCAL Platform for MR Treatment
Part 2
PASCAL MR Live Case – Patient Presentation and Strategy
Part 3
PASCAL Platform – Successful and Durable Treatment of MR
Part 4
PASCAL MR Live Case and Panel Discussion
Part 5
The PASCAL Platform for TR Treatment
Part 6
PASCAL Platform – Safe and Successful Treatment of TR
Part 7
Live Case Wrap-up and Panel Discussion
Part 8
The Future of TR Treatment with the Tricuspid Replacement System, and Event Summary
Faculty Biographies
Didier Tchétché
Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.
In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.
Philipp Lurz
University Medical Center Mainz, Mainz, Germany
Prof Philipp Lurz is Director of the Department of Cardiology Universitätsmedizin Mainz, Germany. Prior to this, he served as Deputy Head of the Department at Heart Center Leipzig, Germany. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.
Peter Lüdike
Senior Physician
Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.
Sam Dawkins
Consultant Cardiologist
Dr Sam Dawkins is a Consultant Cardiologist at the John Radcliffe Hospital in Oxford. He has expertise in general cardiology, interventional cardiology and is a specialist in valve intervention, including TAVI and MitraClip.
Andreas Rück
Dr Andreas Rück is the head of the Transcatheter Aortic Valve Implantation (TAVI) program at Karolinska University Hospital – Stockholm, Sweden and the chairman of the Swedish Percutaneous Valve Registry (a registry within the Swedish Heart Registries SWEDEHEART). He is member of the steering group of SWEDEHEART and of the Working group for PCI and Valve Interventions within the Swedish Society of Cardiology. His clinical specialties include PCI and percutaneous valve implantation.
Nicole Karam
Prof Nicole Karam is an associate professor in the Department of Cardiology at the European Hospital Georges Pompidou. She specializes in interventional cardiology and performs both coronary and valvular percutaneous surgeries, as well as research in Cardiovascular Epidemiology at the French National Institute of Health and Medical Research.
After starting her medical studies at Saint-Joseph University in Beirut, she moved to Paris in 2010 and specialized in Interventional Cardiology. Subsequently, she trained in a highly specialized center for valvular heart disease in Munich, Germany, where she learned new techniques in percutaneous valvular interventions that she later brought back to Georges Pompidou Hospital.
Prof Karam is an active member and a fellow of the European Society of Cardiology, and a member of the steering committee of the Women’s European Association of Percutaneous Cardiovascular Interventions.
Jorg Hausleiter
Deputy Clinic Director
An interventional cardiologist expert in the field of valvular and coronary heart diseases, Prof Dr Jorg Hausleiter is Professor of Medicine and the Deputy Clinic Director at the Ludwig-Maximilian Universitat in Munich, Germany. He is invested in bringing new and innovative technologies into clinical practice.
Michael Böhm
Director Internal Medicine Clinic III, Angiology and Intensive Care Medicine
Dr Michael Böhm performed his medical training at the Medical School of Hannover in Germany. Residency in Internal Medicine and fellowships in Cardiology at the Ludwig Maximilians-Unversity in Munich/Germany at the Klinikum Großhadern; Heisenberg Graduate of the Deutsche Forschungsgemeinschaft; Assistant and Associate Dr of Internal Medicine and Cardiology at the Universität zu Köln in Germany.
Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. Dr Böhm's special interest includes pathophysiology and therapy of heart failure. Particular, he is involved in studies on signal transduction in the failing heart and in vascular biology. Dr Böhm has been the principal investigator in several international multicenter studies. He has written more than 350 original papers, book chapters and review articles. He has obtained several awards of scientific societies. Dr Böhm is a reviewer for…